Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
D000328:Adult; D000368:Aged; D018951:Antigens, CD20 / Q000032:analysis; D001402:B-Lymphocytes; D001781:Blood Component Removal / Q000592:standards; D002469:Cell Separation / Q000379:methods; D018450:Disease Progression; D005260:Female; D006085:Graft Survival; D006801:Humans; D008212:Lymphocyte Depletion / Q000379:methods*; D008224:Lymphoma, Follicular / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating / Q000473:pathology; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D016019:Survival Analysis; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D018951:Antigens, CD20